28 results on '"García-Ortiz, Almudena"'
Search Results
2. Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
3. NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
4. OA-02 α-NKG2A blockade overcomes multiple myeloma resistance to BCMA and NKG2D CAR-NKAE cells
5. Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
6. P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
7. S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
8. Nitric Oxide Signaling in T Cell-Mediated Immunity
9. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
10. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
11. PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma
12. Overcoming tumor resistance mechanisms in CAR-NK cell therapy
13. P-015: Comprehensive comparison of allogenic CAR NK cells for MM treatment
14. P-007: Exploring a safety switch in NKG2D and BCMA CAR NK-92MI immunotherapy
15. CD155 on Multiple Myeloma Cells Is Epigenetically Regulated, Reduce Patients Survival and Compromises the Action of Novel Immunotherapies
16. Personalized Monitoring of Circulating Tumor DNA By a Specific Signature of Trackable Mutations after Chimeric Antigen Receptor t-Cell Therapy in Non-Hodgkin B Cell Lymphoma
17. The role of tumor microenvironment in multiple myeloma development and progression
18. Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma
19. Erm proteins at the crossroad of leukocyte polarization, migration and intercellular adhesion
20. Erm proteins at the crossroad of leukocyte polarization, migration and intercellular adhesion
21. The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
22. ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion
23. Exploring NKG2D and BCMA-CAR NK-92 for Adoptive Cellular Therapy to Multiple Myeloma
24. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
25. eNOS S-nitrosylates ß-actin on Cys374 and regulates PKC-¿ at the immune synapse by impairing actin binding to profilin-1
26. Increase of Mitochondrial Activity Contributes to the Bortezomib-Relapsed in Multiple Myeloma, a Novel Therapeutic Opportunity
27. eNOS S-nitrosylates β-actin on Cys374 and regulates PKC-θ at the immune synapse by impairing actin binding to profilin-1
28. Nitrosothiols in the Immune System: Signaling and Protection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.